# Developmental Research Program

> **NIH NIH P50** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2020 · $88,865

## Abstract

PROJECT SUMMARY/ABSTRACT: Developmental Research Program
The overall objective of the Developmental Research Program (DRP) within the Vanderbilt-Ingram Cancer
Center SPORE in Gastrointestinal (GI) Cancer (hereafter, VICC GI SPORE) is to encourage innovative
translational research in GI neoplasia. The DRP will be led by a Director (R. Daniel Beauchamp, MD) and will
be supported by the Developmental Research Advisory Committee (DRAC) made up of senior investigators at
Vanderbilt and Meharry Medical College (MMC). The DRP leadership has significant crossover with the Career
Enhancement Program (CEP) leadership to encourage CEP recipients to apply for DRP funding and to identify
promising investigators from DRP for the CEP. The VICC GI SPORE DRP will use an established and highly
effective procedure to solicit applications from investigators at Vanderbilt, MMC, and Tennessee State
University. The Director and the DRAC will also actively solicit applications from targeted investigators (women
and underrepresented minorities) within the three institutions. Internal and external researchers, including
members of the GI SPORE External Advisory Board, will review applications using the NIH 9-point scoring
system. Reviewers will evaluate scientific merit and the likelihood of the project to support current GI SPORE
activities, lead to extramural funding, and/or lead to future GI SPORE projects. Special emphasis will be placed
on attracting young investigators into GI cancer research, high risk/high gain projects, and projects that
incorporate emerging technologies and apply them to GI cancer research. Thus, the VICC GI SPORE DRP will
offer the opportunity for new directions of study that may be of higher risk but also have a significant chance for
reward, including independent funding and additional projects that may form the basis of the next competing
renewal.

## Key facts

- **NIH application ID:** 9975138
- **Project number:** 5P50CA236733-02
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** Robert Daniel Beauchamp
- **Activity code:** P50 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $88,865
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9975138

## Citation

> US National Institutes of Health, RePORTER application 9975138, Developmental Research Program (5P50CA236733-02). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9975138. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*